Predictive Oncology to Raise $344.4 Million to Launch ATH Token Treasury Strategy

BlockBeats News, September 29th, Medical equipment company Predictive Oncology Inc. (NASDAQ: POAI) today announced that it has priced two private placement transactions to support the implementation of its digital asset treasury strategy, with the core holding asset being the native utility token of the Aethir ecosystem, ATH.

The company will conduct two public offering private investment in public equity (PIPE) transactions totaling approximately $344.4 million for the purchase and sale of common stock and pre-funded warrants:

Cash PIPE: The company will issue approximately 67 million shares of common stock (or common stock equivalents in pre-funded warrants) at a price of $0.7751 per share, with a total cash gross proceeds of approximately $51.7 million.
Crypto PIPE: The company will issue up to 223.6 million pre-funded warrants at a price per warrant of the offering price minus $0.01, in exchange for a nominal value of approximately $292.7 million, convertible into approximately $173.3 million discount value in the form of contributed lock-up and non-lock-up Aethir tokens.

The pre-funded warrants in the Crypto PIPE will be immediately exercisable upon shareholder approval. It is expected that both PIPE transactions will be completed around October 2, 2025, subject to usual closing conditions. The company plans to use the contributed Aethir (ATH) tokens to implement its digital asset treasury strategy and utilize the remaining net proceeds from the PIPE primarily to acquire ATH on the open market to further support this strategy, as well as for working capital and general corporate purposes.